Skip to main content
. 2020 Oct 13;12(10):2946. doi: 10.3390/cancers12102946

Figure 4.

Figure 4

Inhibitory signaling is diminished in melanoma responders, whereas BCC responders experience increased inhibitory signaling. (A,E) Probability of signaling and averaged expression of the ligand/receptor/downstream target in each cell population for melanoma (A) and BCC (E). (BD) Signaling of the Fc fragment of IgG receptor IIb (FCGR2B) (B), interleukin 6 (IL6) (C), PD1 (D) pathways for melanoma. (FH) Signaling of the FCGR2B (F), IL6 (G), PD1 (H) pathways for BCC.